thrombin signaling promotes pancreatic adenocarcinoma through par-1–dependent immune evasion
Published 3 years ago • 14 plays • Length 2:55Download video MP4
Download video MP3
Similar videos
-
3:33
immunosuppression in pancreatic adenocarcinoma is dependent of glutamine utilizing metabolic pathway
-
1:26
immune checkpoint inhibition for pancreatic ductal adenocarcinoma a systematic review
-
2:53
cancer-foxp3 identifies pancreatic ductal adenocarcinoma patients for immunotherapy
-
1:56
algorithm for the diagnosis, staging, and treatment of pancreas masses (pancreatic adenocarcinoma)
-
0:36
advances in treatment for pancreatic cancer
-
7:03
the concept of pan-tumour therapeutics
-
0:41
pancreatic cancer sequencing project: dr. hruban
-
3:44
hsp70 modulates immune response in pancreatic cancer
-
2:54
targeting chemokines/chemokine receptors facilitates the immunotherapy of pancreatic ductal
-
2:03
thrombin generation as a predictor of outcomes in patients with intracerebral hemorrhage
-
5:52
choosing upfront therapy for metastatic pancreatic cancer
-
16:20
medical management of metastatic pancreatic endocrine neoplasms
-
4:57
the work of the national pancreas foundation
-
0:54
targeting local recurrence in pancreatic adenocarcinoma with proton therapy
-
3:13
abundance of sphingomyelin n-acyl-fatty-acid chain length inversely correlates w/ pancreatic cancer
-
4:44
sequencing strategies for metastatic pancreatic cancer
-
5:46
predictors of advanced neoplasia in surgically resected intraductal papillary mucinous neoplasms
-
6:24
clinical trial panc-001 video
-
3:18
alcam as a novel circulating tumor cell marker for pancreatic ductal adenocarcinoma